1200TiP Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
| Autor: | Orer, H.S., Nomak, G., Oksuzoglu, B., Senturk, R., Eralp, Y., Yumuk, F., Nomak, H., Sanyal, R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1097-S1097 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|